NSE · AMRUTANJAN · Pharmaceuticals
Amrutanjan Health Care Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹192 Cr with net profit ₹21 Cr — a 10.69% net margin, versus 8.71% the period before.
Shareholding
As of 2026-06-30
- Promoter46.52%
- Public38.76%
- FII2.44%
- DII12.28%
45,135 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.6× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Pharmaceuticals - Indian - Formulations · ranked #16 of 50 by market cap · medians across 43 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Torrent Pharmaceuticals Limited | ₹1,87,807 Cr | 84.17 | 22.33 | 25.49% | 13.95% |
| Gland Pharma Limited | ₹48,365 Cr | 42.21 | 4.67 | 9.92% | 16.78% |
| Ajanta Pharma Limited | ₹44,312 Cr | 39.05 | 9.79 | 23.33% | 19.65% |
| Rubicon Research Limited | ₹27,647 Cr | 95.93 | 21.45 | 19.14% | 14.89% |
| Caplin Point Laboratories Ltd. | ₹21,285 Cr | 31.99 | 6.32 | 17.88% | 29.09% |
| Shilpa Medicare Ltd. | ₹20,411 Cr | 71.77 | 7.88 | 9.39% | 17.67% |
| Eris Lifesciences Limited | ₹17,669 Cr | 26.9 | 4.53 | 15.87% | 20.04% |
| Marksans Pharma Limited | ₹15,362 Cr | 29.74 | 5.08 | 13.82% | 16.29% |
| Bliss GVS Pharma Ltd. | ₹7,549 Cr | 54.83 | 6.33 | 10.82% | 13.55% |
| Senores Pharmaceuticals Limited | ₹6,529 Cr | 51.67 | 6.99 | 12.36% | 18.59% |
| Amrutanjan Health Care Ltd.(this company) | ₹1,455 Cr | 23.39 | 3.93 | 17.42% | 10.55% |
AI analysis
AI-generated · google/gemini-2.5-flashAmrutanjan Health Care Ltd. is listed with a market capitalization of Rs 1556 Cr. The company reported annual revenue of Rs 469.5 Cr and an EPS of 17.58. As of June 30, 2026, promoter holding stands at 46.5164%.
Positives
- +The company's debt-to-equity ratio is very low at 0.01.
- +The Return on Capital Employed (ROCE) is 23.3056%.
- +Promoter pledge is 0%, indicating no shares have been pledged.
- +ROE of 16.5% indicates efficient use of shareholder funds.
Negatives
- −No annual revenue growth figure is provided in the data.
- −The profit margin for the company is not disclosed in the data.
- −No dividend yield information is available.
- −The 'about' field for the company's business activities is not specified.
- −No quarterly results have been disclosed since March 2026.
Financial Performance
The company's latest annual revenue was Rs 469.5 Cr. Quarterly revenue for the period ending March 2026 was Rs 149.77 Cr, with a net profit of Rs 16.19 Cr. For the quarter ending December 2025, revenue was Rs 141.04 Cr and net profit was Rs 19.45 Cr.
Profitability & Returns
Amrutanjan Health Care Ltd. achieved a Return on Equity (ROE) of 16.5% and a Return on Capital Employed (ROCE) of 23.3056%. The company's EPS was 17.58, and it trades at a PE ratio of 36.68.
Balance Sheet
The company maintains a low debt-to-equity ratio of 0.01. The book value per share is 112.97. These figures indicate a strong financial position with minimal reliance on debt financing.
Ownership & Pledges
As of June 30, 2026, the promoter holding in Amrutanjan Health Care Ltd. is 46.5164%. The public shareholding is 38.7615%. Total institutional holding is 14.7221%. There are no promoter shares pledged.
Regulatory & Surveillance
The company is not currently under any surveillance measure based on the provided data.
Data as of — price: 2026-09-23 · financials: Mar 16 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Amrutanjan Health Care Ltd.share price & fundamentals